Nasdaq-listed Prenetics Global, a global diagnostic and genetic testing company, has acquired a majority stake in ACT Genomics, an Asia-based genomics company specialising in precision oncology with operations in Hong…
Nasdaq-listed Prenetics Global, a global diagnostic and genetic testing company, has acquired a majority stake in ACT Genomics, an Asia-based genomics company specialising in precision oncology with operations in Hong…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


